✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Archit Organosys Ltd.

ARCHITORG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹93 Cr.
P/E
28.46

Archit Organosys Ltd.

  • Archit Organosys
  • Alkali Metals
  • Par Drugs & Chem.
FAQs on Archit Organosys Ltd. Shareprice

Archit Organosys has given lower returns compared to its competitors.
Archit Organosys has grown at ~-9.97% over the last 2yrs while peers have grown at a median rate of -8.05%

Archit Organosys is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Archit Organosys is 28.93, while 3 year average PE is 17.81.
Also latest EV/EBITDA of Archit Organosys is 8.98 while 3yr average is 10.18.

View FAQ's On Business
Growth Table
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Balance Sheet
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Cash Flow
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Quarterly Results
  • Archit Organosys Ltd.
  • Alkali Metals
  • Par Drugs & Chem.
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Archit Organosys Ltd. Financials

Balance sheet of Archit Organosys is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Archit Organosys is decreasing.
Latest net debt of Archit Organosys is ₹20.7 Crs as of Mar-24.
This is less than Mar-23 when it was ₹25.19 Crs.

The profit is oscillating.
The profit of Archit Organosys is ₹3.28 Crs for Mar 2024, ₹11.35 Crs for Mar 2023 and ₹8.23 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Archit Organosys latest dividend payout ratio is 9.04% and 3yr average dividend payout ratio is 13.87%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech